Interactive Case Management
Sessions in NETs
Webcast CME Disclosure
Please read this notice and click the acknowledgement
at the bottom of the page to continue.
Estimated Time to Complete Educational Activity
In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in metastatic enteropancreatic neuroendocrine tumors
May 21, 2015
May 21, 2017
Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period May 12, 2015 through May 12, 2017, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view the segment totaling 0.50 hours to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out your CME certificate.
Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Supported by an educational grant from Ipsen.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Medical School and CMEducation Resources, LLC. Complete Conference Management is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Massachusetts Medical School designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Faculty & Provider Disclosure
It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Program Faculty and Disclosure
EDWARD M. WOLIN, MD
Professor of Medicine
University of Kentucky
Director of Neuroendocrine Oncology
Director of GI Oncology
Director of Clinical Research
University of Kentucky Medical Center
Consultant: Ipsen, Novartis, Celgene
JAMES C. YAO, MD
Department of Gastrointestinal Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Consultant: Ipsen, Novartis
Grant/Research Support: Novartis
PAMELA L. KUNZ, MD
Professor of Medicine
Director, Neuroendocrine and GI Oncology Program
Director of Clinical Research
Markey Cancer Center, University of Kentucky
Research Funding: Genentech, Merck, Advanced Accelerator Applications, Lexicon Pharmaceuticals, Novartis, Oxigene
Advisor: Guardant Health, Ipsen, Novartis
Stock: Guardant Health
Program Managers and Web Editor Disclosure
Program Manager Gideon Bosker, MD has nothing to disclose.
Program Reviewer Denise Leary has nothing to disclose.
Upon completion of this activity, participants will be able to:
- Detail the epidemiology, burden, and clinical challenges associated with detecting, diagnosing and classifying gastroenteropancreatic neuroendocrine tumors (GEP-NETs);
- Be more clinically proficient at managing metastatic GEP-NETs at the front lines of oncology practice;
- Determine which patients with metastatic GEP-NET are appropriate for surgical interventions (resection), medical therapy, systemic chemotherapy, and peptide receptor-targeted radiotherapy, based on presentation, symptoms, tumor types and stage, clinical profiles, extent of disease, biomarkers, and other factors;
- Identify, assess, and deploy evidence-based treatments for metastatic GEP-NETs based on such outcomes and factors a prolongation of PFS, convenience, patient toleration, and long-term clinical results based on landmark trials and clinical registries;
- Deploy emerging pharmacologic treatments for patients with GEP-NETs, including somatostatin analogs (SSAs), radiolabeled SSAs, cytotoxic drugs, angiogenesis inhibitors, and mammalian target of rapamycin (mTOR) inhibitors in patients with metastatic GEP-NETs;
Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:
- We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
- For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
- We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
- If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
Copyright © 2015 by CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.
||I have read
this CME information statement and wish to participate in this CME
Copyright © CMEducation Resources, LLC